Dowling-Degos disease: Classic clinical and histopathological presentation;Doença de Dowling-Degos: Apresentação clínica e histopatológica clássica

Anais Brasileiros de Dermatologia

Volumn 86, Issue 5, 2011, Pages 979-982

  Zimmermann, Carolina Cotta ^a   Sforza, Deborah ^a   de Macedo, Priscila Marques ^a   Azulay Abulafia, Luna ^b   Alves, Maria de Fatima G S ^b   Carneiro, Sueli Coelho da S ^b  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Genetic; Hyperpigmentation; Keratin 5; Skin diseases

Indexed keywords

ADULT; ARTICLE; AXILLA; BACK; CASE REPORT; CLINICAL EVALUATION; CLINICAL FEATURE; DOWLING DEGOS DISEASE; FACE; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; INGUINAL REGION; MALE; NECK; PSEUDOCYST; SCAR; SKIN BIOPSY; SKIN CYST; SKIN DEFECT; SKIN DISEASE; THORAX;

EID: 83755195638     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962011000500016     Document Type: Article

References (13)

1. Kim YC, Davis MD, Schanbacher CF, Su WP. Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases. J Am Acad Dermatol. 1999;40:462-7.
2. Schnur RE, Heymann WR. Reticulate Hyperpigmentation. Semin Cutan Med Surg. 1997;16:72-80.
3. Azulay-Abulafia L, Porto JA, Souza MAJ, Wrobel R, Brito MA, Valverde RV. Doença de Dowling-Degos. An Bras Dermatol. 1992;67:275-8.
4. Betz RC, Planko L, Eigelshoven S, Hanneken S, Pasternack SM, Bussow H, et al. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet. 2006;78:510-9.
5. Chang MW. Disorders of Hyperpigmentation. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. London: Mosby Elsevier; 2008. p.1820-5.
6. Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas: a disorder that may be caused by a single underlying defect in pilsebaceous epithelial proliferation. J Am Acad Dermatol. 1991;24:888-92.
7. McCormack CJ, Cowen P. Harber's syndrome. Australas J Dermatol. 1997;38:82-4.
8. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Harber's syndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009;160:215-7.
9. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease? J Am Acad Dermatol. 2001;45:760-3.
10. Gilchrist H, Jackson S, Morse L, Nicotri T, Nesbitt LT. Galli-Galli disease: A case report with review of the literature. J Am Acad Dermatol. 2008;58:299-302.
11. Wenzel G, Petrow W, Tappe K, Gerdsen R, Uerlich WP, Bieber T. Treatment of Dowling-Degos disease with Er:YAG-laser: results after 2,5 years. Dermatol Surg. 2003;29:1161-2.
12. Bhagwat PV, Tophakhane RS, Shashikumar BM, Noronha TM, Naidu V. Three cases of Dowling Degos disease in two families. Indian J Dermatol Venereol Leprol. 2009;75:398-400.
13. Oppolzer G, Schwarz T, Duschet P, Brenner W, Gschnait F. Dowling-Degos disease: unsuccessful therapeutic trial with retinoids. Hautarzt. 1987;38:615-8.